RECRUITINGOBSERVATIONAL
Persistent COVID-19 Registry in Navarre.
Persistent COVID-19 Registry in Navarre. (Persicov-19)
About This Trial
The goal of this observational study is to deepen our understanding of long COVID by determining the prevalence of the main complications and medium- to long-term sequelae of COVID-19 in Navarre. Sociodemographic variables such as age, sex, ethnicity, smoking history, and comorbidities will be collected, as well as clinical and disease management variables such as persistent COVID-19 symptoms at 3 months, all with the aim of characterizing patients with long COVID. All patient data will be collected in a single visit.
Who May Be Eligible (Plain English)
Who May Qualify:
- History of confirmed SARS-CoV-2 infection
- Presentation of symptoms that have persisted for more than 3 months after SARS-CoV-2 infection
- The patient reports any of the symptoms listed in the clinical assessment questionnaire or checklist.
Who Should NOT Join This Trial:
- The symptom(s) referred to already existed prior to acute SARS-CoV-2 infection.
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* History of confirmed SARS-CoV-2 infection
* Presentation of symptoms that have persisted for more than 3 months after SARS-CoV-2 infection
* The patient reports any of the symptoms listed in the clinical assessment questionnaire or checklist.
Exclusion Criteria:
* The symptom(s) referred to already existed prior to acute SARS-CoV-2 infection.
Locations (1)
Hospital Universitario de Navarra
Pamplona, Navarre, Spain